Literature DB >> 2408529

Chemotherapy for large-cell lymphoma: optimism and caution.

M Coleman.   

Abstract

Mesh:

Substances:

Year:  1985        PMID: 2408529     DOI: 10.7326/0003-4819-103-1-140

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  5 in total

1.  Adding high-dose tamoxifen to CHOP does not influence response or survival in aggressive non-Hodgkin's lymphoma: an interim analysis of a randomized phase III trial.

Authors:  A A Ezzat; E M Ibrahim; R K Stuart; D Ajarim; S Bazarbashi; M O El-Foudeh; M Rahal; A Al-Sayed; J Berry
Journal:  Med Oncol       Date:  2000-02       Impact factor: 3.064

2.  Induction of the WAF1/CIP1 protein and apoptosis in human T-cell leukemia virus type I-transformed lymphocytes after treatment with adriamycin by using a p53-independent pathway.

Authors:  R B Gartenhaus; P Wang; P Hoffmann
Journal:  Proc Natl Acad Sci U S A       Date:  1996-01-09       Impact factor: 11.205

3.  Evidence of an association between non-Hodgkin's lymphoma and skin cancer.

Authors:  J Adami; M Frisch; J Yuen; B Glimelius; M Melbye
Journal:  BMJ       Date:  1995-06-10

4.  Interpreting outcome data in hematological malignancies: a paradigm for clinical studies.

Authors:  Jacob M Rowe
Journal:  Rambam Maimonides Med J       Date:  2013-01-30

5.  T-cell phenotype is associated with decreased survival in non-Hodgkin's lymphoma.

Authors:  K Shimizu; N Hamajima; K Ohnishi; K Hara; A Kunii
Journal:  Jpn J Cancer Res       Date:  1989-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.